133 related articles for article (PubMed ID: 18760195)
21. [Cell cycle: regulation and abnormalities in epidermal tumors].
Heenen M
Ann Dermatol Venereol; 1997; 124(6-7):452-6. PubMed ID: 9739908
[TBL] [Abstract][Full Text] [Related]
22. Cloning and characterization of murine p16INK4a and p15INK4b genes.
Quelle DE; Ashmun RA; Hannon GJ; Rehberger PA; Trono D; Richter KH; Walker C; Beach D; Sherr CJ; Serrano M
Oncogene; 1995 Aug; 11(4):635-45. PubMed ID: 7651726
[TBL] [Abstract][Full Text] [Related]
23. The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma.
Tsuda H; Yamamoto K; Inoue T; Uchiyama I; Umesaki N
Br J Cancer; 2000 Feb; 82(3):675-82. PubMed ID: 10682682
[TBL] [Abstract][Full Text] [Related]
24. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
Linardopoulos S; Street AJ; Quelle DE; Parry D; Peters G; Sherr CJ; Balmain A
Cancer Res; 1995 Nov; 55(22):5168-72. PubMed ID: 7585567
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
Lai S; El-Naggar AK
Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061
[TBL] [Abstract][Full Text] [Related]
26. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
27. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
28. In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell lines.
Chan HH; Xiang L; Leung JC; Tsang KW; Lai KN
Lasers Surg Med; 2003; 32(2):88-93. PubMed ID: 12561040
[TBL] [Abstract][Full Text] [Related]
29. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
Brambilla E; Moro D; Gazzeri S; Brambilla C
J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
[TBL] [Abstract][Full Text] [Related]
30. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
[TBL] [Abstract][Full Text] [Related]
31. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
[TBL] [Abstract][Full Text] [Related]
32. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.
Schutte M; Hruban RH; Geradts J; Maynard R; Hilgers W; Rabindran SK; Moskaluk CA; Hahn SA; Schwarte-Waldhoff I; Schmiegel W; Baylin SB; Kern SE; Herman JG
Cancer Res; 1997 Aug; 57(15):3126-30. PubMed ID: 9242437
[TBL] [Abstract][Full Text] [Related]
33. Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.
Martinez JC; Palomino JC; Samaniego R; Sepulveda JM; Cabello A; Ricoy JR
Cancer; 2008 Jul; 113(1):166-74. PubMed ID: 18459177
[TBL] [Abstract][Full Text] [Related]
34. Molecular biology of basal and squamous cell carcinomas.
Emmert S; Schön MP; Haenssle HA
Adv Exp Med Biol; 2014; 810():234-52. PubMed ID: 25207369
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma.
Paolini F; Carbone A; Benevolo M; Silipo V; Rollo F; Covello R; Piemonte P; Frascione P; Capizzi R; Catricalà C; Venuti A
J Exp Clin Cancer Res; 2011 Nov; 30(1):108. PubMed ID: 22082146
[TBL] [Abstract][Full Text] [Related]
36. Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.
Wang GY; Wood CN; Dolorito JA; Libove E; Epstein EH
Oncogene; 2017 Jun; 36(26):3772-3780. PubMed ID: 28263978
[TBL] [Abstract][Full Text] [Related]
37. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
Kudchadkar R; Lewis K; Gonzalez R
Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
[TBL] [Abstract][Full Text] [Related]
38. In situ identification of genes regulated specifically in fibroblasts of human basal cell carcinoma.
Micke P; Kappert K; Ohshima M; Sundquist C; Scheidl S; Lindahl P; Heldin CH; Botling J; Ponten F; Ostman A
J Invest Dermatol; 2007 Jun; 127(6):1516-23. PubMed ID: 17273163
[TBL] [Abstract][Full Text] [Related]
39. Understanding the Molecular Genetics of Basal Cell Carcinoma.
Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
[TBL] [Abstract][Full Text] [Related]
40. Involvement of p16 and PTCH in pathogenesis of melanoma and basal cell carcinoma.
Cretnik M; Poje G; Musani V; Kruslin B; Ozretic P; Tomas D; Situm M; Levanat S
Int J Oncol; 2009 Apr; 34(4):1045-50. PubMed ID: 19287961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
